EFFICACY AND SAFETY OF ROFLUMILAST CREAM 0.15% IN ADULTS AND CHILDREN AGED 6 AND OLDER WITH MILD TO MODERATE ATOPIC DERMATITIS IN TWO PHASE 3 INTEGUMENT TRIALS

被引：0
|
作者：
Simpson, E. [1 ]
Eichenfield, L. F. [2 ,3 ]
Gooderham, M. [4 ,5 ]
Gonzalez, M. [6 ]
Hebert, A. A. [7 ]
Papp, K. A. [8 ]
Prajapati, V [9 ,10 ]
Krupa, D. [11 ]
Burnett, P. [11 ]
Berk, D. R. [11 ]
Higham, R. [11 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Rady Childrens Hosp, San Diego, CA 92103 USA
[4] Prob Med Res, SKiN Ctr Dermatol, Peterborough, ON, Canada
[5] Queens Univ, Peterborough, ON, Canada
[6] Pediat Skin Res LLC, Miami, FL USA
[7] UT Hlth McGovern Med Sch, Houston, TX USA
[8] Prob Med Res & Alliance Clin Res, Waterloo, ON, Canada
[9] Univ Calgary, Dermatol Res Inst, Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[10] Prob Med Res, Calgary, AB, Canada
[11] Arcutis Biotherapeut Inc, Westlake Village, CA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO136
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [21] Efficacy And Safety Of Crisaborole In Patients Aged 3 Months To 17 Years With Mild-To-Moderate Atopic Dermatitis
    Su, John C.
    Spelman, Lynda J.
    Eichenfield, Lawrence F.
    Stein, Linda F.
    Cha, Amy
    Graham, Daniela
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    PEDIATRICS, 2021, 147 (03)
  • [22] Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials
    Gold, Linda Stein
    Del Rosso, James
    Ehst, Benjamin D.
    Zirwas, Matthew J.
    Green, Lawrence J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Tallman, Anna M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [23] Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis
    Paller, A. S.
    Simpson, E. L.
    Siegfried, E. C.
    Cork, M. J.
    Wollenberg, A.
    Arkwright, P. D.
    Soong, W.
    Gonzalez, M. E.
    Schneider, L. C.
    Sidbury, R.
    Lockshin, B.
    Wang, Z.
    Mannent, L. P.
    Amin, N.
    Sun, Y.
    Laws, E.
    Akinlade, B.
    Kosloski, M. P.
    Dubost-Brama, A.
    O'Malley, J. T.
    Bansal, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E173 - E173
  • [24] Efficacy and safety of dupilumab in children aged ≥6 months to <6 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sidbury, Robert
    Lockshin, Benjamin
    Xiao, Jing
    O'Malley, John T.
    Bansal, Ashish
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 561 - 561
  • [25] Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Cork, Michael J.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sun, Yiping
    O'Malley, John T.
    Bansal, Ashish
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 12 - 12
  • [26] EFFICACY AND SAFETY OF DUPILUMAB IN CHILDREN AGED 6 MONTHS TO 5 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Worrell, Richard
    Paller, Amy S.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sidbury, Robert
    Lockshin, Benjamin
    Dubost-Brama, Ariane
    Bansal, Ashish
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 31 - 32
  • [27] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
    Tofte, Susan J.
    Papp, Kim
    Sadick, Neil
    Bohnert, Krista
    Simpson, Eric
    Thaci, Diamant
    Bieber, Thomas
    Blauvelt, Andrew
    Sofen, Howard
    Gooderham, Melinda
    Chen, Zhen
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 (09): : 529 - 541
  • [28] Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Thaci, Diamant
    Irvine, Alan D.
    Gold, Linda Stein
    Blauvelt, Andrew
    Simpson, Eric L.
    Chu, Chia-Yu
    Liu, Zhuqing
    Lima, Renata Gontijo
    Pillai, Sreekumar G.
    Seneschal, Julien
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (12): : 1080 - 1091
  • [29] Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials
    Zirwas, Matthew J.
    Boguniewicz, Mark
    Rosmarin, David
    Fuxench, Zelma Chiesa
    Warren, Richard B.
    Torres, Tiago
    de Bruin-Weller, Marjolein
    Dawson, Zach
    Atwater, Amber Reck
    Elmaraghy, Hany
    Pierce, Evangeline
    Bardolet, Laia
    Zhong, Jinglin
    Armstrong, April W.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 54 - 56
  • [30] Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age
    Silverberg, Jonathan, I
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Simpson, Eric
    Gold, Linda Stein
    Bissonnette, Robert
    Papp, Kim A.
    Browning, John
    Kwong, Pearl
    Korman, Neil J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Somerville, Matthew C.
    Tallman, Anna M.
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II17 - II18
12345